The case revolves around Novartis' contention that MSN's generic contains small amounts of crystalline forms of the active ingredients in Entresto that would infringe a patent on the drug (No ...
After hours: February 3 at 6:17:20 PM EST Loading Chart for IMMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback